Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 85 are a HOLD (18.81%), 352 are a BUY (77.88%), 15 are a SELL (3.32%).
Analyst Yigal Nochomovitz, currently employed at CITI, carries an average stock price target met ratio of 47.11% that have a potential upside of 50.31% achieved within 160 days.
Yigal Nochomovitz’s has documented 906 price targets and ratings displayed on 52 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 22-May-2025.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 12/24/2015. The price target of $19 was fulfilled within 4 days with a profit of $16.57 (46.58%) receiving and performance score of 116.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$13
2 years 9 months 30 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold
2 years 10 months 4 days ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold
$20
2 years 10 months 4 days ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy
$15.25
$27
2 years 10 months 5 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
$15.25
$30
2 years 10 months 5 days ago
(23-Aug-2022)
1/3 (33.33%)
$0.09 (0.59%)
48
Which stock is Yigal Nochomovitz is most bullish on?
Which stock is Yigal Nochomovitz is most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?